(Date:11/21/2008)...ov. 21 Symmetry Medical ...r of products to the global orthopedic device indu...at Brian S. Moore, President and Chief Executive O...d Chief Financial Officer, are scheduled to presen...ference at The New York Palace Hotel on Wednesday,...
(Date:11/21/2008)... Innerscope Research(TM), a revolu...g in Emotional Response Measurement,announced to...trengthen the,company,s research and development,... The three appointments, who deliver a combin...as Chief Financial Officer and Vice President of,...
(Date:11/21/2008)... Tobacco use is more prevalent and smoking cessati...t Hyperactivity Disorder (A.D.H.D.) In a study of...symptoms, those who exhibited elevated hyperactivi...howed lower quit rates after 8 weeks than those wi... A.D.H.D. symptoms. The study, now available onli...
(Date:11/21/2008)..., Panama - The University of Texas M. D. Anderson ...ive effort to eradicate breast cancer in Panama th...and Research of the Americas today at an event wit... and Vivian Fernndez de Torrijos, the First Lady o...iative are the U.S. Department of State and Susan ...
Breaking Medicine News(10 mins):Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research extends to Panama 2... to measure the physiological levels of zinc has b...lly pave way// for new approach to study human dis...ry supplement to millions of health-conscious peop...ntists who study its role in Alzheimer's disease, ...
... State University has thrown light on certain pers...an attention// deficit hyperactivity disorder or c...show up as aggressiveness, undue mood swings, aloo...ment are said to be under high risk. FSU psycholo...
...sociated with danger, is also the color of blood, ...eed of nearly 8,000 units// of blood on a daily ba...d of blood. The Footballers of Sunderland have set...to donate blood that will surely offset shortages,...
...rug addicts, to check out if they really have the ...eed to tide over drug tests// to prove their child...ing chewed upon by Peter Peacock, the children's m...ht of drug tests that might hold a clue to how the...
Other Medicine News:(Date:11/21/2008)...wswire-FirstCall/ -- Amgen,(Nasdaq: AMGN ) toda...nal,Products for Human Use (CHMP) has issued a po...on for Nplate(TM) (romiplostim) in the European Un...hronic immune (idiopathic),thrombocytopenia purpu...y to,other treatments (e.g. corticosteroids, immu...
(Date:11/21/2008)...Newswire-FirstCall/ -- , - Not for UK Journ...al Products for Human Use (CHMP) today,announced ...brel(R),(etanercept) as a treatment for children ... plaque psoriasis. If approved by the European,Co..., Enbrel will become the,first biologic treatment...
(Date:11/21/2008)...-- Ikaria Holdings, Inc. today announced that it h...ew Jersey Technology Council (NJTC), a 1,200-membe...upport, networking opportunities, information and ...s. Ikaria earned the award based on criteria inclu...provision. , , "We are delighted that the N...
(Date:11/20/2008)...ire/ -- Epeius Biotechnologies,announced today th...in,chemotherapy-resistant metastatic soft tissue ...t P. Chawla, principal investigator, at the CTOS 1... 13-15, 2008. Patients received,repeated infusion...alysis of,safety and efficacy data showed no majo...
Breaking Medicine Technology:Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 2Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 3Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 4Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 5Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 6Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 7Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 8CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2Susan G Komen for the Cure 28C 29 Opens Registration For 19th Annual Susan G Komen National Race for the Cure 28C 29 15713 1Susan G Komen for the Cure 28C 29 Opens Registration For 19th Annual Susan G Komen National Race for the Cure 28C 29 15713 2Susan G Komen for the Cure 28C 29 Opens Registration For 19th Annual Susan G Komen National Race for the Cure 28C 29 15713 3Susan G Komen for the Cure 28C 29 Opens Registration For 19th Annual Susan G Komen National Race for the Cure 28C 29 15713 4Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13 15 2008 in Spearfish SD 15711 1Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13 15 2008 in Spearfish SD 15711 2Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13 15 2008 in Spearfish SD 15711 3Mayo Clinic Proceedings Examines a Possible Link Between Bacteria Found in the Human Digestive System and Obesity 15709 1Mayo Clinic Proceedings Examines a Possible Link Between Bacteria Found in the Human Digestive System and Obesity 15709 2Mayo Clinic Proceedings Examines a Possible Link Between Bacteria Found in the Human Digestive System and Obesity 15709 3CoAxia 28TM 29 Announces 2411 5M Equity Financing From Existing Investors 1669 1CoAxia 28TM 29 Announces 2411 5M Equity Financing From Existing Investors 1669 2...07 /PRNewswire-FirstCall/ -- Amylin,Pharmaceutical...proved diabetes drugs, BYETTA(R) (exenatide) injec..., and its pipeline,candidates will be presented at...nual Scientific Sessions being held in Chicago, IL... investor,presentation during the meeting that wil...
... - ConjuChem Biotechnologies (TSX:CJB),today anno...(TM):Exendin-4 Albumin Conjugate for the treatmen... Scientific,Sessions of the American Diabetes Ass...cago, IL. The ADA,s annual,Scientific Sessions mee...are professionals involved in diabetes research,a...
Other Medicine Technology:Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 2Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 3Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 4ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin,Conjugate Data Presented at American Diabetes Association Annual,Meeting 2ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin,Conjugate Data Presented at American Diabetes Association Annual,Meeting 3High sensitive, specific one step immunochromatographic assay for human infectious disease
High sensitive, specific one step immunochromatographic assay for human infectious disease
Span Diagnostics Limited
Paracheck Pf is a two site sandwich immunoassay for the detection of P. falciparum specific histidine rich protein 2 (Pf HRP-2) in whole blood samples.
Medicine Products: